Endometrial Cancer News and Research

RSS
ESMO 2024: Promising results in immunotherapy and antibody drug conjugates for gynecological cancers

ESMO 2024: Promising results in immunotherapy and antibody drug conjugates for gynecological cancers

Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers

Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers

New cancer drug shows encouraging results in Phase I/II trial

New cancer drug shows encouraging results in Phase I/II trial

ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers

ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers

Targeted therapy slows endometrial cancer growth in mice models

Targeted therapy slows endometrial cancer growth in mice models

FDA accepted PD-L1 inhibitor durvalumab for the treatment of endometrial cancer

FDA accepted PD-L1 inhibitor durvalumab for the treatment of endometrial cancer

New treatment option for endometrial cancer shows promise in phase II trial

New treatment option for endometrial cancer shows promise in phase II trial

Study: Many women unaware postmenopausal bleeding signals endometrial cancer

Study: Many women unaware postmenopausal bleeding signals endometrial cancer

Antibody-drug conjugate shows preclinical efficacy

Antibody-drug conjugate shows preclinical efficacy

New guidelines can help alleviate unnecessary referrals related to unexpected bleeding

New guidelines can help alleviate unnecessary referrals related to unexpected bleeding

GLP-1 drugs found to lower cancer risk in diabetes patients

GLP-1 drugs found to lower cancer risk in diabetes patients

AI identifies new high-risk subtype in endometrial cancer

AI identifies new high-risk subtype in endometrial cancer

Study exposes algorithmic inequity in endometrial cancer detection for Black women

Study exposes algorithmic inequity in endometrial cancer detection for Black women

UBC researchers use AI to improve endometrial cancer diagnosis and treatment

UBC researchers use AI to improve endometrial cancer diagnosis and treatment

Mayo Clinic researchers uncover microbial signatures linked to gynecologic cancers

Mayo Clinic researchers uncover microbial signatures linked to gynecologic cancers

Immune checkpoint protein VISTA can directly turn off T-cells during immunotherapy, study finds

Immune checkpoint protein VISTA can directly turn off T-cells during immunotherapy, study finds

Proteins in the blood could warn people of cancer more than seven years before it is diagnosed

Proteins in the blood could warn people of cancer more than seven years before it is diagnosed

Breast cancer survivors at higher risk of developing second cancers

Breast cancer survivors at higher risk of developing second cancers

NCCN 2024 Annual Conference focuses on practical applications for improving cancer care

NCCN 2024 Annual Conference focuses on practical applications for improving cancer care

Study provides reassurance regarding the safety of using hormone therapy after age 65 years

Study provides reassurance regarding the safety of using hormone therapy after age 65 years

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.